In vitro activity of zoliflodacin against Neisseria gonorrhoeae collected in the United States from 2020 to 2022
{{output}}
Zoliflodacin is a first-in-class spiropyrimidinetrione, oral, single-dose antibacterial recently approved by the US FDA for treatment of uncomplicated urogenital gonorrhea. Isolates of Neisseria gonorrhoeae (n = 322) collected in the United States in 2020-2022... ...
